SciClone is a publicly-held corporation based in Foster City, California, and trades on the NASDAQ Global Select Market under the symbol SCLN
) - Financial and Strategic SWOT Analysis Review
En la coleccion de publicaciones del SCLN
han aparecido varios volumenes de Buxo sobre literatura novohispana, y estos especificamente acerca de la llamada Decima Musa: El enamorado de Sor Juana.
Activities, service, and other information discussed in the second section include: state library users; state library collection; collection statistics; DISCUS--South Carolina's virtual library; information services; South Carolina State Documents Depository Program; consultant services; grant administration; children's services; continuing education; public library construction; marketing/public information services; legislation; collaborations; the South Carolina Library Network (SCLN
); Internet/telecommunications project; South Carolina Group Database Licensing Project; staff development; volunteer program; facilities; and customer needs assessment.
), San Mateo, Calif., has completed the planned enrollment of 500 patients in the first of its two phase 3 hepatitis C (HCV) clinical trials evaluating its lead immune system enhancing drug ZADAXIN.
Tickers featured: AICX, BDX, BEC, BJCT, CERN, CVSN, CYTC, DGX, DIAN, DIGE, HEPH, IDXC, IMPH, JNJ, LH, MCK, MEDW, MRGE, PATH, RHHVF, SCLN
, SGP, SRA, TPTH, VMSI.
) has received an unsolicited, nonbinding proposal, from a consortium led by investment firms GL Capital Management GP Ltd.
(PAV282) DONALD SELLERS - SCICLONE PHARMACEUTICALS INC (SCLN
Tickers featured: ABGX, ABT, ALLP, AMGN, AMLN, AVE, AVGN, BGEN, BMY, CEGE, CRA, DNA, DOW, DVSA, FBR, GILD, GNVC, HGSI, IDBE, IDPH, IMCL, IMNX, ISIS, JNJ, KERX, LLY, MEDI, MLNM, NWBT, ONXX, SCLN
, SRA, SYT, TELK, TRMS, TTP, VICL.
(PAX625) DONALD SELLERS - SCICLONE PHARMACEUTICALS INC (SCLN
(NAH314) DONALD SELLERS - SCICLONE PHARMACEUTICALS INC (SCLN
12 January 2011 - US SciClone Pharmaceuticals Inc (NASDAQ: SCLN
) reported on Tuesday the enrollment of the first patient in its Phase IIb study of SCV-07 for the prevention of oral mucositis (OM).